Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda system on the sensitivity and specificity of the papanicolaou test: A 5-year follow-up study of papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria Academic Article uri icon

Overview

MeSH Major

  • Papanicolaou Test
  • Vaginal Smears

abstract

  • The ASCUS threshold established by B2001 prevents a sizeable subset of women from having follow-up for ASC. However, as a consequence, a few women with CIN 2/3 are downgraded to NILM. The cost savings thus achieved must be weighed against the lost opportunities to detect CIN 2/3.

publication date

  • June 25, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.23538

PubMed ID

  • 18454461

Additional Document Info

start page

  • 171

end page

  • 9

volume

  • 114

number

  • 3